Literature DB >> 9014829

MUTZ-3, a monocytic model cell line for interleukin-4 and lipopolysaccharide studies.

H Quentmeier1, A Duschl, Z B Hu, B Schnarr, M Zaborski, H G Drexler.   

Abstract

The human monocytic cell lines MUTZ-3 and MONO-MAC-6 express the lipopolysaccharide (LPS) receptor CD14. Paralleling the situation in peripheral blood monocytes (PBMo), recombinant human interleukin-4 (IL-4) down-regulated the expression of CD14 on the cell surface of MUTZ-3, but not that of MONO-MAC-6 cells. In addition, preincubation with IL-4 prevented the LPS-induced up-regulation of IL-1 beta mRNA levels in MUTZ-3, but not in MONO-MAC-6 cells. We examined whether the differential responsiveness of the cell lines was due to the missing expression of the IL-4 receptor (IL-4R) alpha or gamma c chain in MONO-MAC-6 cells. Flow cytometric and immunoprecipitation analysis revealed expression of both IL-4R chains in both cell lines. In addition, short-term stimulation with IL-4 induced tyrosine-phosphorylation of the gamma c chain. As both cell lines also expressed signal transducer and activator of transcription 6 (STAT 6), our data suggested that the differential reaction patterns of MUTZ-3 and MONO-MAC-6 cells were not due to a generally defective IL-4R complex. Interestingly, long-term (48 hr) treatment with LPS rendered MONO-MAC-6 cells sensitive to IL-4. LPS up-regulated expression of monocyte-specific esterase (MSE) mRNA as well as CD14 protein in MONO-MAC-6 cells; both effects were inhibited by IL-4. This stimulation was not paralleled by an increase of IL-4R mRNA or protein expression supporting the above hypothesis of a constitutively present and active IL-4R. We discuss possible causes for the differential reaction patterns of MUTZ-3 and MONO-MAC-6 cells to IL-4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014829      PMCID: PMC1456585          DOI: 10.1046/j.1365-2567.1996.d01-780.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Effect of cytokines and lipopolysaccharide on CD14 antigen expression in human monocytes and macrophages.

Authors:  R Landmann; C Ludwig; R Obrist; J P Obrecht
Journal:  J Cell Biochem       Date:  1991-12       Impact factor: 4.429

2.  Interleukin 4 down-regulates the expression of CD14 and the production of interleukin 6 in acute myeloid leukemia cells.

Authors:  J H Jansen; W E Fibbe; G J Wientjens; J Van Damme; J E Landegent; R Willemze; J C Kluin-Nelemans
Journal:  Lymphokine Cytokine Res       Date:  1991-12

3.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

4.  IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency.

Authors:  J Ruppert; D Friedrichs; H Xu; J H Peters
Journal:  Immunobiology       Date:  1991-08       Impact factor: 3.144

5.  Interleukin 4 down-regulates the expression of CD14 in normal human monocytes.

Authors:  R P Lauener; S M Goyert; R S Geha; D Vercelli
Journal:  Eur J Immunol       Date:  1990-11       Impact factor: 5.532

6.  Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.

Authors:  Z B Hu; W Ma; M Zaborski; R MacLeod; H Quentmeier; H G Drexler
Journal:  Leukemia       Date:  1996-06       Impact factor: 11.528

7.  An interleukin-4-induced transcription factor: IL-4 Stat.

Authors:  J Hou; U Schindler; W J Henzel; T C Ho; M Brasseur; S L McKnight
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

8.  Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts.

Authors:  R P Donnelly; L J Crofford; S L Freeman; J Buras; E Remmers; R L Wilder; M J Fenton
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

9.  IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells.

Authors:  L M Wang; M G Myers; X J Sun; S A Aaronson; M White; J H Pierce
Journal:  Science       Date:  1993-09-17       Impact factor: 47.728

10.  Interleukin-4 inhibits the lipopolysaccharide-induced expression of c-jun and c-fos messenger RNA and activator protein-1 binding activity in human monocytes.

Authors:  W H Dokter; M T Esselink; M R Halie; E Vellenga
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113

View more
  5 in total

1.  Microdevice integrating innate and adaptive immune responses associated with antigen presentation by dendritic cells.

Authors:  Bhaskar Mitra; Rohit Jindal; Serom Lee; Dave Xu Dong; Lulu Li; Nripen Sharma; Tim Maguire; Rene Schloss; Martin L Yarmush
Journal:  RSC Adv       Date:  2013-07-05       Impact factor: 3.361

2.  Perspectives on Non-Animal Alternatives for Assessing Sensitization Potential in Allergic Contact Dermatitis.

Authors:  Nripen S Sharma; Rohit Jindal; Bhaskar Mitra; Serom Lee; Lulu Li; Tim J Maguire; Rene Schloss; Martin L Yarmush
Journal:  Cell Mol Bioeng       Date:  2012-03       Impact factor: 2.321

3.  Glycan-binding profile of DC-like cells.

Authors:  Eugenia M Rapoport; Ekaterina V Moiseeva; Dmitry A Aronov; Sergey V Khaidukov; Galina V Pazynina; Svetlana V Tsygankova; Ivan M Ryzhov; Ivan M Belyanchikov; Tatiana V Tyrtysh; Kenneth C McCullough; Nicolai V Bovin
Journal:  Glycoconj J       Date:  2019-12-13       Impact factor: 2.916

4.  Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.

Authors:  Andy Forreryd; Henrik Johansson; Ann-Sofie Albrekt; Carl A K Borrebaeck; Malin Lindstedt
Journal:  PLoS One       Date:  2015-03-11       Impact factor: 3.240

5.  The pathogen receptor liver and lymph node sinusoidal endotelial cell C-type lectin is expressed in human Kupffer cells and regulated by PU.1.

Authors:  Angeles Domínguez-Soto; Laura Aragoneses-Fenoll; Fernando Gómez-Aguado; María Teresa Corcuera; Joan Clária; Carmelo García-Monzón; Matilde Bustos; Angel L Corbí
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.